Anand Sampath, EVP, Operations & Clinical Research at MASIMO CORP (MASI), sold 15,000 shares at $155.00 ($2.3M) on 2019-11-20, disclosed to the SEC on 2019-11-21.
Open-market sale of $2.3M MASI by EVP, Operations & Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MASI | SELL | 2020-04-15 | $3.6M | — | Filing → |
| MASI | SELL | 2019-06-18 | $4.3M | — | Filing → |
| MASI | SELL | 2019-01-16 | $3.5M | — | Filing → |